Analysts Downgrade Merck and Pfizer on Patent Cliff, Exclusivity Concerns - IPWatchdog.com

Analysts Downgrade Merck and Pfizer on Patent Cliff, Exclusivity Concerns  IPWatchdog.com

Last month, business news outlets were reporting that stock prices for pharmaceutical firms Pfizer and Merck took a tumble after financial analysts downgraded ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases